Expression of FGD3 gene as prognostic factor in young breast cancer patients

被引:0
|
作者
Irene Renda
Simonetta Bianchi
Vania Vezzosi
Jacopo Nori
Ermanno Vanzi
Ketty Tavella
Tommaso Susini
机构
[1] University of Florence,Breast Unit, Gynecology Section, Department of Health Sciences
[2] University of Florence,Pathology Unit, Department of Health Sciences
[3] Azienda Ospedaliero-Universitaria Careggi,Diagnostic Senology Unit
[4] Azienda Ospedaliero-Universitaria Careggi,Medical Oncology Unit
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The FGD3 gene works as a cell migration inhibitor and seems to be a promising indicator of outcome in some human cancers including breast. In this study, we analysed for the first time the prognostic role of FGD3 in young breast cancer patients. We studied the relationship between traditional prognostic factors, FGD3 expression and outcome in ≤40 years breast cancer patients. We found that lower FGD3 expression decreased the probability of disease-free survival (p = 0.042) and overall survival (p = 0.007). In a multivariate analysis for overall survival AJCC stage (p = 0.005) and FGD3 expression (p = 0.03) resulted independent prognostic factors. Low FGD3 expression increased the risk of death from disease (HR 5.73, p = 0.03). Moreover, low FGD3 expression was associated with more widespread lymph node involvement (p = 0.04) and a lower FGD3 staining intensity was found in positive-lymph-node patients vs negative (p = 0.003) and in patients with ≥10 involved lymph nodes vs <10 (p = 0.05). Our results suggest FGD3 to be a significant independent prognostic factor in young breast cancer patients in terms of disease-free survival and overall survival. A lower expression increased the risk of recurrence and death from disease and was associated with widespread lymph node metastases.
引用
收藏
相关论文
共 50 条
  • [21] Expression of growth factor receptors is not a prognostic indicator in young patients with colorectal cancer
    Langlois, N
    Walker, LG
    Smith, I
    Skinner, L
    Eremin, O
    Heys, SD
    JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, 1997, 42 (02): : 98 - 101
  • [22] Significance of p85 expression as a prognostic factor for patients with breast cancer
    Zhou, Weiwei
    An, Guangyu
    Wei, Ping
    Chen, Wenming
    ONCOLOGY LETTERS, 2014, 8 (04) : 1657 - 1661
  • [23] LKB1 expression is an independent prognostic factor for breast cancer patients
    Sueta, Aiko
    Fujiki, Yoshitaka
    Tomiguchi, Mai
    Takeshita, Takashi
    Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    CANCER SCIENCE, 2018, 109 : 522 - 522
  • [24] EMI2 expression as a poor prognostic factor in patients with breast cancer
    Vadhan, Anupama
    Wang, Yen-Yun
    Yuan, Shyng-Shiou F.
    Lee, Yi-Chen
    Hu, Stephen Chu-Sung
    Huang, Jyun-Yuan
    Ishikawa, Takashi
    Hou, Ming-Feng
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2020, 36 (08): : 640 - 648
  • [25] Is sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?
    Sozzani, Prisca
    Arisio, Riccardo
    Porpiglia, Mauro
    Benedetto, Chiara
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2008, 16 (04) : 365 - 374
  • [26] Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
    Huang, Du-Ping
    Ma, Rui-Min
    Xiang, You-Qun
    MEDICINE, 2016, 95 (17)
  • [27] Prognostic significance of α- and β2-adrenoceptor gene expression in breast cancer patients
    Mariano Rivero, Ezequiel
    Martinez, Leandro Marcelo
    David Bruque, Carlos
    Gargiulo, Lucia
    Bruzzone, Ariana
    Alicia Luthy, Isabel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 2143 - 2154
  • [28] Expression profiling as a prognostic and predictive factor in breast cancer
    van't Veer, LJ
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S11 - S11
  • [29] Expression profiling as a prognostic and predictive factor in breast cancer
    LJ van 't Veer
    Breast Cancer Research, 7
  • [30] Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients
    Vincenzi, B.
    Santini, D.
    Perrone, G.
    Russo, A.
    Adamo, V.
    Rizzo, S.
    Castri, F.
    Antinori, A.
    Alloni, R.
    Crucitti, P. F.
    Morini, S.
    Rabitti, C.
    Vecchio, F. M.
    Magistrelli, P.
    Coppola, R.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2009, 20 (01) : 78 - 83